Client News

Newron announces Paragraph IV ANDA filing for Xadago(R) (safinamide) in the USA

Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2021

Vetter and Rentschler Biopharma Further Strengthen their Strategic Alliance

XPhyto Pursues Market Access in Israel for its COVID-19 PCR Rapid Test

Marinomed Biotech AG announces positive data demonstrating Carragelose efficacy against SARS-CoV-2 variants

ADOCIA Announces First Quarter 2021 Financial Results

XPhyto Signs German Distribution, Storage and Logistics Agreement for 25-Minute COVID-19 PCR Test

Abivax Hosting Key Opinion Leader Webinar on ABX464 for the Treatment of Ulcerative Colitis

Abivax completes induction treatment of last patient in ABX464 phase 2b clinical study in ulcerative colitis

Abivax publishes data of ABX464 induction and long-term maintenance phase 2a ulcerative colitis study in the prestigious journal “Gastroenterology”